Advertisement
AMPH vs PBH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and PBH is a Buy.
AMPH in +5.28% Uptrend, rising for three consecutive days on October 30, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AMPH advanced for three days, in 257 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on AMPH as a result. In 59 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for AMPH just turned positive on October 30, 2026. Looking at past instances where AMPH's MACD turned positive, the stock continued to rise in 33 of 46 cases over the following month. The odds of a continued upward trend are 72%.
The 50-day moving average for AMPH moved above the 200-day moving average on October 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Bearish Trend Analysis
The 10-day RSI Indicator for AMPH moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 30 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
AMPH broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMPH entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. AMPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.497) is normal, around the industry mean (8.029). P/E Ratio (15.534) is within average values for comparable stocks, (-0.853). Projected Growth (PEG Ratio) (0.640) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1.522) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
PBH in upward trend: price rose above 50-day moving average on October 29, 2026
PBH moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 62 cases where PBH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on PBH as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for PBH just turned positive on October 29, 2026. Looking at past instances where PBH's MACD turned positive, the stock continued to rise in 24 of 37 cases over the following month. The odds of a continued upward trend are 65%.
The 10-day moving average for PBH crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +2.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in 167 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Aroon Indicator entered an Uptrend today. In 127 of 229 cases where PBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
PBH broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. PBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.229) is normal, around the industry mean (8.029). P/E Ratio (13.891) is within average values for comparable stocks, (-0.853). Projected Growth (PEG Ratio) (1.482) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (2.042) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
AMPH | PBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 87 | 100 | |
SMR RATING 1..100 | 69 | 74 | |
PRICE GROWTH RATING 1..100 | 38 | 57 | |
P/E GROWTH RATING 1..100 | 8 | 49 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMPH's Valuation (57) in the Pharmaceuticals Other industry is in the same range as PBH (62). This means that AMPH’s stock grew similarly to PBH’s over the last 12 months.
AMPH's Profit vs Risk Rating (87) in the Pharmaceuticals Other industry is in the same range as PBH (100). This means that AMPH’s stock grew similarly to PBH’s over the last 12 months.
AMPH's SMR Rating (69) in the Pharmaceuticals Other industry is in the same range as PBH (74). This means that AMPH’s stock grew similarly to PBH’s over the last 12 months.
AMPH's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as PBH (57). This means that AMPH’s stock grew similarly to PBH’s over the last 12 months.
AMPH's P/E Growth Rating (8) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (49). This means that AMPH’s stock grew somewhat faster than PBH’s over the last 12 months.
| AMPH | PBH | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 68% | N/A |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 58% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 55% |
| Advances ODDS (%) | 5 days ago 78% | 2 days ago 52% |
| Declines ODDS (%) | 12 days ago 67% | 14 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 55% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMPH’s FA Score shows that 1 FA rating(s) are green while PBH’s FA Score has 0 green FA rating(s).
- AMPH’s FA Score: 1 green, 4 red.
- PBH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMPH’s TA Score shows that 4 TA indicator(s) are bullish while PBH’s TA Score has 7 bullish TA indicator(s).
- AMPH’s TA Score: 4 bullish, 5 bearish.
- PBH’s TA Score: 7 bullish, 2 bearish.
Price Growth
AMPH (@Pharmaceuticals: Generic) experienced а +6.12% price change this week, while PBH (@Pharmaceuticals: Generic) price change was +3.28% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.43%. For the same industry, the average monthly price growth was -7.19%, and the average quarterly price growth was +2.27%.
Reported Earning Dates
AMPH is expected to report earnings on Nov 05, 2026.
PBH is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-1.43% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
PBH and
Correlation & Price change
A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PRGO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PRGO could also see price increases.
| Ticker / NAME | Correlation To PBH | 1D Price Change % | ||
|---|---|---|---|---|
| PBH | 100% | +1.37% | ||
| PRGO - PBH | 35% Loosely correlated | -0.19% | ||
| AMPH - PBH | 32% Poorly correlated | -2.49% | ||
| ANIP - PBH | 31% Poorly correlated | -1.85% | ||
| ELAN - PBH | 29% Poorly correlated | +4.51% | ||
| HLN - PBH | 29% Poorly correlated | +1.15% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CAF | 15.84 | 0.20 | +1.28% |
| Morgan Stanley China A Share Fund | |||
| XXX | 20.99 | -0.03 | -0.12% |
| CYBER HORNET S&P 500 and XRP 75/25 Strategy ETF (XXX) | |||
| EVHY | 50.93 | -0.07 | -0.14% |
| Eaton Vance High Yield ETF (EVHY) | |||
| QQQJ | 43.56 | -0.38 | -0.86% |
| Invesco NASDAQ Next Gen 100 ETF (QQQJ) | |||
| BWTG | 41.30 | -0.55 | -1.32% |
| Brendan Wood TopGun ETF (BWTG) | |||